Literature DB >> 18703703

Lack of endogenous TRIM5alpha-mediated restriction in rhesus macaque dendritic cells.

Nathalie J Arhel1, Sébastien Nisole, Laetitia Carthagena, Frédéric Coutant, Philippe Souque, Audrey Brussel, Jérôme Estaquier, Pierre Charneau.   

Abstract

Rhesus macaques are resistant to infection by HIV-1 as a result of an innate cellular restriction mechanism attributable to the expression of rhTRIM5alpha, a member of the large tripartite motif (TRIM) protein family. TRIM5alpha-mediated restriction, which occurs before reverse transcription through targeting of the HIV-1 capsid, has been identified in a number of macaque primary cells and cell lines and is thought to occur in all macaque cell types. We report, however, that rhesus macaque dendritic cells (DCs) lack TRIM5alpha-mediated restriction and are equally permissive to HIV-1 infection as human DCs. Evidence suggests that, although TRIM5alpha RNA levels are normal in these cells, the protein may be dysfunctional. We propose that abrogation of TRIM5alpha-mediated restriction in DCs, although still operative in cells that replicate HIV-1 (macrophages, T lymphocytes), illustrates the need for innate mechanisms to not inhibit adaptive immune responses to ensure an optimal fight against pathogens.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18703703     DOI: 10.1182/blood-2008-04-151761

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  Replication potentials of HIV-1/HSIV in PBMCs from northern pig-tailed macaque (Macaca leonina).

Authors:  Ai-Hua Lei; Gao-Hong Zhang; Ren-Rong Tian; Jia-Wu Zhu; Hong-Yi Zheng; Wei Pang; Yong-Tang Zheng
Journal:  Dongwuxue Yanjiu       Date:  2014-05

2.  Lentiviral vector-based prime/boost vaccination against AIDS: pilot study shows protection against Simian immunodeficiency virus SIVmac251 challenge in macaques.

Authors:  Anne-Sophie Beignon; Karine Mollier; Christelle Liard; Frédéric Coutant; Sandie Munier; Julie Rivière; Philippe Souque; Pierre Charneau
Journal:  J Virol       Date:  2009-08-12       Impact factor: 5.103

3.  Development and use of SIV-based Integrase defective lentiviral vector for immunization.

Authors:  Zuleika Michelini; Donatella R M Negri; Silvia Baroncelli; Massimo Spada; Pasqualina Leone; Roberta Bona; Mary E Klotman; Andrea Cara
Journal:  Vaccine       Date:  2009-06-11       Impact factor: 3.641

4.  Suppressor of cytokine signaling 1 counteracts rhesus macaque TRIM5α-induced inhibition of human immunodeficiency virus type-1 production.

Authors:  Sayaka Sukegawa; Ryuta Sakuma; Seiga Ohmine; Hiroaki Takeuchi; Yasuhiro Ikeda; Shoji Yamaoka
Journal:  PLoS One       Date:  2014-10-13       Impact factor: 3.240

5.  TRIM5α is a SUMO substrate.

Authors:  Jacques Dutrieux; Débora M Portilho; Nathalie J Arhel; Uriel Hazan; Sébastien Nisole
Journal:  Retrovirology       Date:  2015-03-24       Impact factor: 4.602

Review 6.  The TRIMendous Role of TRIMs in Virus-Host Interactions.

Authors:  Sarah van Tol; Adam Hage; Maria Isabel Giraldo; Preeti Bharaj; Ricardo Rajsbaum
Journal:  Vaccines (Basel)       Date:  2017-08-22

7.  Upregulation of innate antiviral restricting factor expression in the cord blood and decidual tissue of HIV-infected mothers.

Authors:  Nátalli Zanete Pereira; Elaine Cristina Cardoso; Luanda Mara da Silva Oliveira; Josenilson Feitosa de Lima; Anna Cláudia Calvielli Castelo Branco; Rosa Maria de Souza Aveiro Ruocco; Marcelo Zugaib; João Bosco de Oliveira Filho; Alberto José da Silva Duarte; Maria Notomi Sato
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240

8.  Endogenous TRIM5α Function Is Regulated by SUMOylation and Nuclear Sequestration for Efficient Innate Sensing in Dendritic Cells.

Authors:  Débora M Portilho; Juliette Fernandez; Mathieu Ringeard; Anthony K Machado; Aude Boulay; Martha Mayer; Michaela Müller-Trutwin; Anne-Sophie Beignon; Frank Kirchhoff; Sébastien Nisole; Nathalie J Arhel
Journal:  Cell Rep       Date:  2015-12-31       Impact factor: 9.423

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.